|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.12 USD | -0.16% |
|
+6.22% | +8.39% |
| 06-16 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 06-10 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | -8.63x | 4.02x | 3.8x | -7.02x | -6.59x | 2.15B | ||
| 0.6% | 0.68% | 16.94x | 1.97x | 3.69x | 9.97x | 10.92x | 66.56B | ||
| 0.56% | 0.58% | 27.98x | 4.21x | 5.76x | 16.9x | 21.36x | 56.51B | ||
| -.--% | -.--% | 35.25x | 7.07x | 11.95x | 22.63x | 26.59x | 42.98B | ||
| 3.37% | 3.46% | -45.47x | 2.48x | 3.2x | 9.47x | 11.04x | 40.46B | ||
| -.--% | -.--% | 34.9x | 1.72x | 3.71x | 11.39x | 13.26x | 31.91B | ||
| -.--% | -.--% | -9.24x | 5.42x | 13.4x | -8.22x | -7.78x | 31.65B | ||
| -.--% | -.--% | 16.96x | 3.4x | 3.25x | 9.83x | 9.74x | 23.35B | ||
| -.--% | 0.05% | 55.23x | 5.58x | 6.16x | 42.67x | 39.46x | 19.46B | ||
| -.--% | -.--% | 26.86x | 3.77x | 5.49x | 14.73x | 20.43x | 17.18B | ||
| -.--% | -.--% | -35.48x | -6.16x | 16.45x | -50.02x | -51.98x | 15.12B | ||
| -.--% | -.--% | -123.95x | 12940.15x | 12.65x | -112.04x | -123.11x | 12.57B | ||
| 0.15% | 0.16% | 62.48x | 25.48x | 37.96x | 53.68x | 55.37x | 11.95B | ||
| -.--% | -.--% | 16.75x | - | 3.57x | 13.08x | 15.68x | 11.4B | ||
| -.--% | -.--% | 48.65x | - | - | - | - | 11.06B | ||
| 2.83% | 3.27% | 11.86x | 1.03x | 1.81x | 7.29x | 9.77x | 6.24B | ||
| 1.45% | 1.61% | 15.54x | 1.43x | 2.85x | 7.37x | 8.93x | 6.23B | ||
| 0.39% | 0.46% | 26.25x | - | 7x | 18.58x | 22.19x | 5.35B | ||
| Average | 0.52% | 0.57% | 9.60x | 866.77x | 8.39x | 3.55x | 4.43x | 22.9B | |
| Weighted average by Cap. | 0.58% | 0.62% | 11.67x | 427.19x | 7.54x | 7.96x | 9.41x |
- Stock Market
- Stocks
- ZLAB Stock
- Sector Zai Lab Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
















